These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1588459)

  • 61. Rubber stoppers as sources of contaminants in electrospray analysis of peptides and proteins.
    Zhang XK; Dutky RC; Fales HM
    Anal Chem; 1996 Sep; 68(18):3288-9. PubMed ID: 8797388
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Panel discussion: impact of changes of rubber formulations. I. Potential impact of changes in raw material availability and performance criteria.
    Keim FM
    J Parenter Drug Assoc; 1978; 32(1):33-6. PubMed ID: 246925
    [No Abstract]   [Full Text] [Related]  

  • 63. Evaluation of the immuno-stimulatory potential of stopper extractables and leachables by using dendritic cells as readout.
    Mueller R; Karle A; Vogt A; Kropshofer H; Ross A; Maeder K; Mahler HC
    J Pharm Sci; 2009 Oct; 98(10):3548-61. PubMed ID: 19226629
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Identification of an Oxidizing Leachable from a Clinical Syringe Rubber Stopper.
    Schröter A; Peter S; Mahler HC; Zerr A; Danton O; Chalus P; Koulov AV; Huwyler J; Jahn M
    J Pharm Sci; 2021 Oct; 110(10):3410-3417. PubMed ID: 34089713
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Observations on the mechanical resistance of neutral glass vials in the lyophilization process].
    Toninato T; Salvagno L; Rigoli A; Moretti C
    Farmaco Prat; 1981 Feb; 36(2):78-88. PubMed ID: 7215530
    [No Abstract]   [Full Text] [Related]  

  • 66. Research on the relationship between cephalosporin structure, solution clarity, and rubber closure compatibility using volatile components profile of butyl rubber closures.
    Chong XM; Dong X; Yao SC; Hu CQ
    Drug Dev Ind Pharm; 2019 Jan; 45(1):159-167. PubMed ID: 30231654
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Strategy for determining extractables from rubber packaging materials in drug products.
    Paskiet DM
    PDA J Pharm Sci Technol; 1997; 51(6):248-51. PubMed ID: 9448435
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Leaching of zinc compound from rubber stoppers into the contents of automatic atropine injectors.
    Ellin RI; Kaminskis A; Zvirblis P; Sultan WE; Shutz MB; Matthews R
    J Pharm Sci; 1985 Jul; 74(7):788-90. PubMed ID: 4032257
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Butyl rubber stoppers increase the shelf life of prereduced, anaerobically sterilized media.
    Fulghum RS; Worthington JM
    Appl Environ Microbiol; 1977 May; 33(5):1220-1. PubMed ID: 879778
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The effect of rubber closures on the haze state of ceftriaxone sodium for injection.
    Zhao X; Jin SH; Hu CQ
    Drug Dev Ind Pharm; 2007 Jan; 33(1):35-44. PubMed ID: 17192249
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmaceutical container/closure integrity. I: Mass spectrometry-based helium leak rate detection for rubber-stoppered glass vials.
    Kirsch LE; Nguyen L; Moeckly CS
    PDA J Pharm Sci Technol; 1997; 51(5):187-94. PubMed ID: 9357304
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pharmaceutical vials with extremely high chemical inertness.
    Walther M; Rupertus V; Seemann C; Brecht J; Hormes R; Swift RW
    PDA J Pharm Sci Technol; 2002; 56(3):124-9. PubMed ID: 12109332
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Extraction rates of marker compounds from rubber closures for parenteral use.
    Boyett JB; Avis KE
    Bull Parenter Drug Assoc; 1975; 29(1):1-17. PubMed ID: 1125469
    [No Abstract]   [Full Text] [Related]  

  • 74. Effect of rubber closures on the stability of stannous ion in reagent kits for radiopharmaceuticals.
    Petry NA; Shaw SM; Kessler WV; Born GS; Belcastro PF
    J Parenter Drug Assoc; 1979; 33(5):283-6. PubMed ID: 259650
    [No Abstract]   [Full Text] [Related]  

  • 75. Loss of preservative from a tuberculin solution in rubber stoppered vials fastened with different seals.
    Held HR; Landi S
    J Biol Stand; 1985 Jul; 13(3):211-9. PubMed ID: 4030793
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Panel discussion: impact of changes of rubber formulations. II. Changes in accelerators.
    Greene GE
    J Parenter Drug Assoc; 1978; 32(1):37-9. PubMed ID: 246926
    [No Abstract]   [Full Text] [Related]  

  • 77. Panel discussion: impact of changes of rubber formulations. III. Impact on the end user.
    Grimes TL
    J Parenter Drug Assoc; 1978; 32(1):40-3. PubMed ID: 246927
    [No Abstract]   [Full Text] [Related]  

  • 78. Extraction rates of marker compounds from rubber closures for parenteral use. II. mechanism of extraction and evaluation of select extraction parameters.
    Boyett JB; Avis KE
    Bull Parenter Drug Assoc; 1976; 30(4):169-79. PubMed ID: 953369
    [No Abstract]   [Full Text] [Related]  

  • 79. ELASTOMERIC CLOSURES FOR PHARMACEUTICAL PACKAGING.
    HOPKINS GH
    J Pharm Sci; 1965 Jan; 54():138-43. PubMed ID: 14288477
    [No Abstract]   [Full Text] [Related]  

  • 80. Interference by butyl rubber stoppers in GLC analysis for theophylline.
    Chrzanowski F; Niebergall PJ; Mayock R; Taubin J; Sugita E
    J Pharm Sci; 1976 May; 65(5):735-6. PubMed ID: 932944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.